Welcome to our dedicated page for Alerian MLP Index ETN SEC filings (Ticker: AMJB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Alerian MLP Index ETN's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Alerian MLP Index ETN's regulatory disclosures and financial reporting.
JPMorgan Chase & Co. filed a Schedule 13G reporting beneficial ownership of 140,932,031 Grupo Televisa, S.A.B. Certificados de Participacion Ordinarios (CPOs) / Global Depositary Shares, representing 5.5% of the class as of 12/31/2025.
JPMorgan reports sole power to vote and dispose of all these securities, with no shared voting or dispositive power. The filing identifies subsidiaries J.P. MORGAN SE, J.P. Morgan Securities PLC, and J.P. Morgan Securities LLC as the relevant entities. JPMorgan certifies the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Grupo Televisa.
JPMorgan Chase Financial Company LLC, fully guaranteed by JPMorgan Chase & Co., is offering auto callable contingent interest notes linked individually to the Nasdaq-100 Index®, the Russell 2000® Index and the State Street® SPDR® S&P® Regional Banking ETF, maturing in January 2029.
The notes can pay a monthly Contingent Interest Payment if on a Review Date the closing value of each underlying is at least 70.00% of its Initial Value, and missed coupons can be paid later if conditions are met. Automatic call can occur as early as July 21, 2026 if each underlying is at or above its Initial Value, returning principal plus applicable interest. If the notes are not called and any underlying finishes below its Trigger Value of 60.00% of Initial Value, repayment is reduced one-for-one with the decline of the least performing underlying, and investors can lose a substantial portion or all of principal.
The hypothetical Contingent Interest Rate is shown as 8.70% per annum, and if priced today the estimated value is about $950.60 per $1,000 note, with a minimum estimated value at issuance of $900.00 per $1,000. The notes are unsecured, subject to the credit risk of JPMorgan Financial and JPMorgan Chase & Co., will not be listed, do not pay dividends on the underlying assets and involve additional risks tied to small-cap, non-U.S. and banking-sector exposures.
JPMorgan Chase Financial Company LLC, fully guaranteed by JPMorgan Chase & Co., is offering Capped Dual Directional Buffered Equity Notes linked to the S&P 500® Index. The notes provide unleveraged upside to the Index, capped at a Maximum Upside Return of at least 13.50%, so the maximum payment at maturity for a positive Index Return is $1,135 per $1,000 note. If the Index falls by up to the 10.00% Buffer Amount, investors still receive a positive return equal to the Index’s absolute decline, up to $1,100 per $1,000 note. If the Index declines by more than 10.00%, principal is lost at 1.11111% for each additional 1% drop. The Index Strike Level is 6,944.47, the S&P 500® closing level on January 15, 2026. The notes have a Valuation Date of April 15, 2027 and a Maturity Date of April 20, 2027, in minimum denominations of $10,000. The issuer indicates that, if priced on the example date, the estimated value would be about $984.70 per $1,000 note and will not be less than $970.00 when finalized.
JPMorgan Chase Financial Company LLC is offering $1,100,000 of capped notes linked to the SPDR® Gold Trust (GLD). The two-year notes, guaranteed by JPMorgan Chase & Co., give 100% participation in any positive fund return but cap gains at a maximum additional amount of $217.50 per $1,000, a 21.75% maximum return at maturity.
If the final GLD share price is at or below the $421.63 share strike price, the payoff is $1,000 plus the fund return, with a minimum of $950 per $1,000 note, so investors can lose up to 5% of principal and forgo any inflation protection. The notes pay no interest or dividends and carry the credit risk of both the issuer and guarantor.
The price to the public is $1,000 per note, including $15 in selling commissions, for net proceeds of $985 per note, or $1,083,500 in total. The estimated value at pricing was $979.50 per $1,000 note, reflecting structuring and hedging costs. For U.S. tax purposes, the issuer intends to treat the notes as contingent payment debt instruments, requiring accrual of original issue discount based on a 4.27% comparable yield.
JPMorgan Chase Financial Company LLC is offering $900,000 of stepdown review notes linked separately to the S&P 500, Russell 2000 and EURO STOXX 50 indices. The notes have $1,000 denominations, no interest payments and can be automatically called on review dates in 2027, 2028 or 2029 if each index is at or above its call level, triggering fixed premiums of 9.90%, 19.80% or 29.70% of principal.
If the notes are not called and the least performing index finishes below 70% of its strike level, principal is reduced 1% for each 1% decline beyond a 30% buffer, up to a total loss. The notes are unsecured obligations of JPMorgan Chase Financial, fully and unconditionally guaranteed by JPMorgan Chase & Co., and will not be listed on an exchange. The price to the public is $1,000 per note, with proceeds to the issuer of $980 per note, and an estimated value of $959.50.
JPMorgan Chase & Co. has filed an amended Schedule 13G reporting its beneficial ownership in Sibanye Stillwater Limited as of 12/31/2025. The firm reports beneficial ownership of 140,082,817 ordinary shares of no par value, representing 4.7% of the class.
JPMorgan Chase & Co. reports sole voting and sole dispositive power over all 140,082,817 shares, with no shared voting or dispositive power. The filing identifies the reporting person as a parent holding company (HC), with J.P. Morgan Securities PLC and J.P. Morgan Securities LLC listed as relevant subsidiaries. The securities are certified as being held in the ordinary course of business and not for the purpose of changing or influencing control of Sibanye Stillwater.
JPMorgan Chase & Co. has filed a Schedule 13G reporting beneficial ownership of 26,628,886 shares of DraftKings Inc. Class A common stock as of 12/31/2025. This stake represents 5.1% of the class, crossing the 5% threshold that triggers this type of ownership disclosure.
JPMorgan reports sole power to vote and dispose of all 26,628,886 shares, with no shared voting or dispositive power. The filing classifies JPMorgan as a parent holding company and lists subsidiaries including J.P. Morgan Structured Products B.V., J.P. MORGAN SE, J.P. Morgan Securities PLC, and J.P. Morgan Securities LLC as involved entities. JPMorgan certifies the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of DraftKings.
JPMorgan Chase & Co. filed a Schedule 13G reporting beneficial ownership of 13,712,039 shares of DocuSign, Inc. common stock, representing 6.4% of the outstanding class as of 12/31/2025. JPMorgan has sole power to vote and dispose of all these shares and no shared voting or dispositive power. The filing classifies JPMorgan as a parent holding company and lists several subsidiaries involved in holding the securities. JPMorgan certifies that the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of DocuSign.
JPMorgan Chase & Co. filed an amended Schedule 13G reporting beneficial ownership of 145,679,951 ordinary shares of Radiopharm Theranostics Limited, as represented by American Depositary Shares. This holding represents 4.0% of the class as of 12/31/2025.
JPMorgan reports sole power to vote and dispose of all 145,679,951 shares, with no shared voting or dispositive power. The firm certifies the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
JPMorgan Chase Financial Company LLC is offering auto callable contingent interest notes linked to the common stock of Tesla, Inc., fully and unconditionally guaranteed by JPMorgan Chase & Co. Each note has a $1,000 minimum denomination.
The notes pay a contingent interest rate of at least 15.75% per annum, credited monthly, but only for Review Dates when Tesla’s closing price is at or above 50% of the Initial Value, which serves as both the Interest Barrier and Trigger Value. The notes may be automatically called starting April 23, 2026 if Tesla’s price on a Review Date (other than the first, second and final) is at or above the Initial Value, returning $1,000 plus the applicable contingent interest.
If not called and Tesla’s final price is at or above the Trigger Value, investors receive $1,000 plus the last contingent interest payment at maturity on January 26, 2029. If the final price is below the Trigger Value, repayment is reduced one-for-one with Tesla’s decline, so investors can lose more than 50% and up to all of their principal. The notes are unsecured, not FDIC insured, not listed on an exchange, and an example estimated value is $969.90 per $1,000 note, with a minimum estimated value of $900.00.